"Attendees should expect to gain an insight into major advances in the industry and an understanding of how the application of technologies can improve the effectiveness of research"
In addition to a free exhibition of the very latest lab equipment and technology for life science research, next week at London's Olympia, Ibla (International Biotech and Lab Automation Europe, 15-16 November 2005) will provide a packed programme of visitor features.
These include scientific poster sessions and technology seminars, which will all be taking place on the show floor.
Also running alongside is the Lab Automation Europe conference which will this year be focusing on new screening and hit-to-lead approaches.
The series of free-to-attend seminars will run on both days in the on-site lecture theatre.
Here the enlightening technology presentations will give visitors the chance to evaluate at first hand some of the many new products, technologies and solutions being launched at Ibla.
Leading companies, including ABGene, Anachem, Caliper Life Sciences, Thermo and Qiagen, will all be presenting their very latest scientific developments, technologies and findings.
The seminars will cover a diverse range of subject matter from discussions on how to boost R and D productivity, through to new liquid handling concepts and microfluidics technologies.
There will also be insights into the future of lab automation and the latest developments in sample management, as well as new Adme/Tox screening solutions.
Attendance is free on a first come first served basis for all Ibla visitors.
Providing a further information resource for visitors, Ibla 2005 will again host scientific research poster sessions.
These will enable those with a professional interest in the life sciences and enabling technologies to stay up to date with the latest scientific research and findings.
Coming from both academia and industry, all posters will be displayed in a specially allocated area of the exhibition.
The poster sessions will provide in-depth insight of many scientific areas, including assessments of new technologies, such as the world's first commercially available mass spectrometer chip based on a quadrupole mass spectrometer and new high speed microfluidics chip technologies for protein analysis.
Reflections on building fully automated high throughput technology systems and new technology for consistent dose delivery of drugs, through to analysis of the world biotech market are also all presented.
The aims of the concurrent Lab Automation Europe Conference, and indeed Ibla, is summed up by Steve Jordan, global head of chemistry for Biotage, and chair of the conference's scientific committee.
"Attendees should expect to gain an insight into major new advances in the industry and an understanding of how the application of new technologies and strategies can improve the overall effectiveness of life science research and drug discovery."
